But for the first time, there's a vaccine that offers significant protection. The newly rolled-out RSV vaccines are ...

GSK CEO Emma Walmsley gave an upbeat assessment of the British drugmaker's new respiratory syncytial virus (RSV) vaccine on ...

Federal officials have been working with companies to find ways to boost the supply of the new vaccine for newborns.

As the battle between new respiratory syncytial virus (RSV) vaccines heats up, GSK is “delighted” with the progress it's made ...

Pregnant women and their babies and adults over 60 years old can be more protected from respiratory syncytial virus, or RSV, ...

Respiratory syncytial virus, or RSV, is a common respiratory virus that spreads seasonally. A new drug and several vaccines that prevent the infection have recently come to market. Here's what you ...

Respiratory syncytial virus, or RSV, is a common illness among young kids. Eighty percent of babies catch it within their first year of life. For some, it can be serious and require hospitalization.

TAMPA, Fla. - Respiratory syncytial virus, more commonly known as RSV, is a respiratory virus that infects the lungs and breathing passages. It affects all age groups, but can be especially serious ...

Despite 50 years of research, there are currently no RSV vaccines approved or in Phase III trials for any of the target populations. High levels of neutralizing antibodies to RSV F protein have ...

Parents struggle to find newly-approved RSV vaccine for babies. Pediatrician explains why. Parents struggle to find newly-approved RSV vaccine for babies. Pediatrician explains why. 03:27 ...

CARMEL, Ind. (Ivanhoe Newswire) – Respiratory syncytial virus, or RSV, is a common illness among young kids. Eighty percent of babies catch it within their first year of life. For some, it can ...

NEW YORK/LONDON (Reuters) -GSK CEO Emma Walmsley gave an upbeat assessment of the British drugmaker's new respiratory ...